Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cochrane Evaluates Survivorship Programs for BC

Cochrane; 2017 Aug 24; Cheng KKin Fong, et al

Publish date:: August 29, 2017

Home-based multidimensional survivorship programs appear to improve both cancer-specific and global quality of life in breast cancer survivors, according to a Cochrane review of 26 studies involving 2,272 individuals. Additionally, home-based multidimensional survivorship programs can reduce anxiety, fatigue, and insomnia. Among the findings:

Home-based multidimensional survivorship programs appear to improve quality of life in the short term.
They also reduce fatigue, insomnia, and anxiety in the short term.
They do not reduce symptoms of depression, flushes, and night sweats when compared with usual care or alternative interventions.
Group-based programs seem to work better than those geared toward individuals.
There are no differences in quality of life with educational, psychological, or physical components of survivorship programs.

Citation:

Cheng KKin Fong, Lim Y, Koh Z, Tam W. Home-based multidimensional survivorship programmes for breast cancer survivors. Cochrane Database of Syst Rev. 2017, Issue 8. Art. No.: CD011152. doi: 10.1002/14651858.CD011152.pub2.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Breast Cancer

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Study: Doctors underreport side effects of breast irradiation,

No edge for anastrozole over tamoxifen in DCIS,

Long-term APBI cosmetic, toxicity data reported WBI has the edge Practice-confirming results,

Omitting postop radiotherapy doesn’t affect survival in older breast cancer patients,